Did you know that humanity generates a staggering 402.74 million terabytes of information every day?
This data deluge is reshaping industries, influencing our lives, and posing unprecedented challenges. One industry that is no exception is clinical research.
Today’s trials are complex, fragmented, and highly dependent on coordination. Data sits in one system, operations in another, and communication somewhere else entirely. The real opportunity for AI is not just to analyze this environment, but to work within it.
According to Tufts CSDD, most sponsors now use at least four data sources, with 98% of organizations reporting issues with their current data management systems.
This means teams are spending large amounts of time integrating, cleaning, and analyzing data that’s often across incompatible systems. The result is typically inefficiencies, increased complexity, and delays.
Problems like this are what Medable’s Agentic AI clinical trial platform, with its multitude of connectors and its Model Context Protocols (MCPs), solves.
From isolated tools to connected workflows
Most traditional AI applications today sit on top of workflows. They summarize, answer, or generate responses, but they do not participate in execution.
Agentic systems change that by connecting directly into data platforms, retrieving and updating data, and maintaining context while moving between systems.
In a clinical setting, this means agents can help coordinate trials in real time and can surface issues, trigger actions, and support teams as work is happening instead of merely reporting on issues.
Our clinical trial connectors
Medable’s strength starts with its deep integration into the systems that actually run clinical trials. These are not horizontal tools, they are systems that define how studies are executed, monitored, and delivered.
Medable connects directly into:
- EDC platforms such as Veeva EDC, Medidata Rave, and Oracle InForm
- eConsent and eCOA through the Medable platform
- CTMS systems like Veeva CTMS
- eTMF platforms such as Veeva eTMF
- IRT systems like Oracle IRT
- Safety and pharmacovigilance systems such as Oracle Argus
- Startup and feasibility tools like Citeline
This layer is what makes the platform uniquely positioned. AI is not limited to analysis. It can operate within the workflows that drive trial execution.
AI and everyday work
Clinical development depends on constant collaboration across teams and partners. AI becomes significantly more useful when it is embedded directly into these workflows.
Medable integrates with collaboration and productivity tools such as:
- Microsoft 365, Teams, Slack, and Google Workspace
- Gmail and Microsoft Outlook
- Storage platforms including Amazon S3, OneDrive, and Box
- Tools like Jira, Confluence, Figma, and Qualio
This allows AI to assist within the flow of work by drafting updates, coordinating tasks, and keeping teams aligned without requiring context switching.
Data and intelligence
Clinical trials generate large volumes of structured and unstructured data. The value comes from connecting and interpreting that data in context.
Medable’s data and intelligence connectors include:
- Semantic data layers such as Cube and bio ontologies
- Data warehouses including BigQuery, Snowflake, and Databricks
- Utility tooling like URL fetching, search, and code environments
With these connections, AI can continuously analyze trial data, identify patterns, and provide insights that are grounded in the full data landscape.
Infrastructure that enables action
Medable connects into infrastructure and platform services including:
- DevOps tools such as GitLab and GitHub
- Identity and access systems like Azure ID, Entra ID, and Medable user administration
- Configuration through Medable Studio
This layer ensures that actions taken by AI are controlled, auditable, and aligned with enterprise requirements.
Supporting global trials at scale
Global trials introduce additional complexity through language, regulation, and patient engagement.
Medable connects into:
- DocuSign for consent workflows
- RWS for translation and localization
These integrations allow AI to support the generation of localized materials, streamline approvals, and ensure consistency across regions.
Toward an AI native clinical operating system
When these layers are connected, a different model begins to take shape. Instead of separate systems that require manual coordination, the platform becomes a unified environment where AI can operate across the full lifecycle of a trial.
An agent can pull data from an EDC system, compare it with safety signals, generate documentation, notify stakeholders, and update dashboards. All of this can happen within a continuous workflow that reflects how trials actually run.
The path forward, what this unlocks for life sciences
Clinical trials run on a complex ecosystem of disconnected systems, making it difficult to unify data, workflows, and teams. The real power of AI comes from its ability to connect across this landscape, integrating directly with the tools that drive clinical development and turning fragmented processes into seamless, intelligent workflows.
This approach changes both the speed and quality of clinical development.
- Workflows become faster because coordination is automated
- Decisions improve because they are based on real-time, connected data
- Teams spend less time navigating systems and more time acting on insights
More importantly, the blockades between data, operations, and communication begin to disappear.
